Skip to content
  • Technology
  • Pipeline
  • Team
  • Partnership
  • Publications
  • Contact us

Author: admin

The magic of small-moleculedrugs during ex vivo expansionin adoptive cell therapy

Posted on November 6, 2023November 6, 2023 by admin
Posted in UncategorizedLeave a Comment on The magic of small-moleculedrugs during ex vivo expansionin adoptive cell therapy

Targeting vasoactive intestinal peptidemediated signaling enhances response toimmune checkpoint therapy in pancreaticductal adenocarcinoma

Posted on November 6, 2023 by admin
Posted in UncategorizedLeave a Comment on Targeting vasoactive intestinal peptidemediated signaling enhances response toimmune checkpoint therapy in pancreaticductal adenocarcinoma

Comparing VIP and PD-L1 expression as cancer biomarkers

Posted on November 6, 2023 by admin
Posted in UncategorizedLeave a Comment on Comparing VIP and PD-L1 expression as cancer biomarkers

Absence of Vasoactive Intestinal Peptide Expression in Hematopoietic Cells EnhancesAbsence of Vasoactive Intestinal Peptide Th1 Polarization and Antiviral Immunity in Mice

Posted on November 6, 2023November 6, 2023 by admin
Posted in UncategorizedLeave a Comment on Absence of Vasoactive Intestinal Peptide Expression in Hematopoietic Cells EnhancesAbsence of Vasoactive Intestinal Peptide Th1 Polarization and Antiviral Immunity in Mice

Administration of a vasoactive intestinal peptide antagonist enhances the autologousanti-leukemia T cell response in murine models of acute leukemia

Posted on November 6, 2023November 6, 2023 by admin
Posted in UncategorizedLeave a Comment on Administration of a vasoactive intestinal peptide antagonist enhances the autologousanti-leukemia T cell response in murine models of acute leukemia

Modulation of Immune Checkpoints andGraft-versus-Leukemia in AllogeneicTransplants by Antagonizing VasoactiveIntestinal Peptide Signaling

Posted on November 6, 2023 by admin
Posted in UncategorizedLeave a Comment on Modulation of Immune Checkpoints andGraft-versus-Leukemia in AllogeneicTransplants by Antagonizing VasoactiveIntestinal Peptide Signaling

VIPhyb, an Antagonist of Vasoactive Intestinal PeptideReceptor, Enhances Cellular Antiviral Immunity in MurineCytomegalovirus Infected Mice

Posted on November 6, 2023 by admin
Posted in UncategorizedLeave a Comment on VIPhyb, an Antagonist of Vasoactive Intestinal PeptideReceptor, Enhances Cellular Antiviral Immunity in MurineCytomegalovirus Infected Mice

Pharmacological inhibition of VIP signaling enhances antiviral immunityand improves survival in murine cytomegalovirus-infected allogeneicbone marrow transplant recipients

Posted on November 6, 2023 by admin
Posted in UncategorizedLeave a Comment on Pharmacological inhibition of VIP signaling enhances antiviral immunityand improves survival in murine cytomegalovirus-infected allogeneicbone marrow transplant recipients

Recent Posts

  • The magic of small-moleculedrugs during ex vivo expansionin adoptive cell therapy
  • Targeting vasoactive intestinal peptidemediated signaling enhances response toimmune checkpoint therapy in pancreaticductal adenocarcinoma
  • Comparing VIP and PD-L1 expression as cancer biomarkers
  • Absence of Vasoactive Intestinal Peptide Expression in Hematopoietic Cells EnhancesAbsence of Vasoactive Intestinal Peptide Th1 Polarization and Antiviral Immunity in Mice
  • Administration of a vasoactive intestinal peptide antagonist enhances the autologousanti-leukemia T cell response in murine models of acute leukemia

Recent Comments

No comments to show.

Archives

  • November 2023

Categories

  • Uncategorized
  • Technology
  • Pipeline
  • Team
  • Partnership
  • Publications
  • Contact us

© 2025 Cambium Oncology. All Rights Reserved